Telix jumps on cancer study update says CEO
MELBOURNE: Shares in cancer-fighter Telix Pharmaceuticals rose 3.8 per cent to $4.14 yesterday after the
MELBOURNE: Shares in cancer-fighter Telix Pharmaceuticals rose 3.8 per cent to $4.14 yesterday after the
FEATURED
Special research team creates ‘predictive medicine’ AI tool
Gen Z fear they will be poorest generation
New development earmarked for hospitality and multigenerational living
Public notification opens for 25-unit project on former landfill
Nine-story homeless tower rejected by council in shock vote
Multigenerational affordable housing planned for regeneration site
INNOVATION
